James & Wilks Pharmacy is an authorized DME supplier for medicare equipments and products.
James & Wilks Pharmacy is a Community/Retail Pharmacy in Dyersburg, Tennessee. This pharmacy is owned and operated by James And Wilks Pharmacy Llc. It is located at 620 Mall Blvd Ste A, Dyersburg and it's customer support contact number is 731-286-2025. The authorized person of James & Wilks Pharmacy is Dr. Mart Whitis James, D.PH who is Pharmacist of the pharmacy and his contact number is 731-445-8923. Active license number of James & Wilks Pharmacy is 5242 for Community/Retail Pharmacy in Tennessee. James & Wilks Pharmacy accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. James & Wilks Pharmacy is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
James & Wilks Pharmacy type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
James & Wilks Pharmacy
Type:
Community/Retail Pharmacy
Location:
620 Mall Blvd Ste A, Dyersburg, Tennessee, 38024-1649
Phone:
731-286-2025
Fax:
731-882-1976
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Dr. Mart Whitis James
Credentials:
D.PH
Position:
Pharmacist
Contact Number:
731-445-8923
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1891123675
NPI Enumeration Date:
14 Oct, 2013
NPI Last Update On:
09 Oct, 2023
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for James & Wilks Pharmacy are as mentioned below.
Specialization
License Number
State
Status
Community/Retail Pharmacy
5242
Tennessee
Primary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
5242
Other
Tennessee
Tennessee Board Of Pharmacy License
Medicare Enrollment:
James & Wilks Pharmacy is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
2264738186
O20160302001922
James And Wilks Pharmacy Llc
PART B SUPPLIER - MASS IMMUNIZATION (ROSTER BILLER ONLY)
2264738186
O20160706002702
James And Wilks Pharmacy Llc
DME SUPPLIER - PHARMACY
Products Available:
James & Wilks Pharmacy has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Non-mail Order
Canes & Crutches
Orthoses: Off-the-shelf
Ostomy Supplies
Surgical Dressings
Urological Supplies
Walkers
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
620 Mall Blvd Ste A, Dyersburg, Tennessee
Zip:
38024-1649
Phone Number:
731-286-2025
Fax Number:
731-882-1978
Patients can reach James & Wilks Pharmacy at 620 Mall Blvd Ste A, Dyersburg, Tennessee or can call on customer care at 731-286-2025.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.